ALL-RISE Trial Examines Two Approaches to Assessing Blocked Heart Arteries

ALL-RISE Trial Examines Two Approaches to Assessing Blocked Heart Arteries

The New England Journal of Medicine has published findings from the ALL-RISE trial, which investigated whether a less invasive angiography-guided method of assessing intermediate coronary artery narrowing performs as well as the established pressure-wire technique.

What the Research Is About

The New England Journal of Medicine (@NEJM) posted about the ALL-RISE trial findings on its official social media channels, drawing attention to a question that sits at the heart of interventional cardiology: when a patient has a coronary artery that appears partially — but not severely — blocked, how should clinicians decide whether it needs treating?

The tweet, posted by the journal’s verified account, states that among patients with intermediate coronary stenosis — a term describing a partial narrowing of the arteries supplying the heart — it remains unknown whether a physiological assessment using an angiography-guided strategy is noninferior to the more established pressure-wire–guided approach. The journal directed followers to a Quick Take video summarising the trial’s findings.

The Clinical Question at Stake

Intermediate coronary stenosis sits in a grey zone. The narrowing is real, but not so severe that the decision to intervene is automatic. Getting that decision right matters — unnecessary procedures carry risks, and missed interventions can leave patients vulnerable to future cardiac events.

The pressure-wire method, long considered the standard physiological assessment tool, involves threading a thin wire into the coronary artery to measure blood flow and pressure directly. It gives clinicians a precise reading of whether a narrowing is genuinely restricting blood supply to the heart muscle. The angiography-guided approach, by contrast, uses imaging data alone — without the wire — to make the same judgement. If the two approaches produce equivalent outcomes, the angiography-guided method could simplify the assessment process for many patients.

According to the NEJM post, the ALL-RISE trial was designed specifically to test whether that equivalence holds.

Why the ALL-RISE Trial Matters

Coronary artery disease remains one of the leading causes of death in England, according to NHS data. Any evidence that a less invasive diagnostic pathway produces comparable outcomes to the current standard could have wide impact on how cardiac catheterisation labs across the country — including those serving Kent and Medway — organise their workloads and manage patient pathways.

But the NEJM’s framing is careful. The post does not claim the angiography-guided strategy is proven equivalent; it describes the question as “unknown” and points to the trial as addressing that gap. The full findings are available via the journal’s Quick Take video summary.

What Remains Unanswered

The social media post does not detail the trial’s sample size, duration, primary endpoints, or the direction of its findings. Those specifics sit within the full published research. It’s also not yet clear whether NHS England or any cardiac network has responded to the trial’s conclusions or indicated whether practice changes are being considered.

Source: @NEJM

Key Takeaways

  • The ALL-RISE trial investigated whether angiography-guided physiological assessment is noninferior to pressure-wire–guided assessment in patients with intermediate coronary stenosis
  • The New England Journal of Medicine published a Quick Take video summarising the research findings
  • The NEJM post describes the question of equivalence between the two strategies as previously “unknown,” positioning the trial as addressing a genuine evidence gap

What This Means for Kent Residents

The Kent and Medway Integrated Care Board oversees cardiac services for a population of around 1.9 million people, and any changes to how intermediate coronary stenosis is assessed could affect how patients are managed at local cardiac units. If you have been told you have a partial narrowing of a coronary artery, or are awaiting a cardiac assessment, you should speak directly with your cardiologist or GP about which diagnostic approach is appropriate for your situation — this article does not constitute medical advice. For general health concerns, NHS 111 is available by phone or online; in an emergency, always call 999.